Company intelligence / Profile preview

Diagonal Bio

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Diagonal Bio has developed and patented a rapid molecular diagnostics technology capable of detecting genetic markers for infectious agents within minutes. Their lead platforms, PANVIRAL and LAMPlify, are designed for point-of-care use with high accuracy comparable to PCR-based methods. The company’s technology allows parallel testing for multiple diseases and patients simultaneously. As of mid–2025, the company appears to be in the late pre-commercial or early commercial phase; no clinical trial results are reported as their products are diagnostic devices rather than therapeutics.

Therapeutic areas: Infectious Diseases
Modalities: Device (diagnostic system)Molecular diagnostics platform
Industry: Molecular Diagnostics

Partnerships

Agreement with a Japanese supplier; seeking additional distribution partners in US, EU, East Asia; exploring joint ventures and license agreements in non-core segments

Beyond the preview

Go deeper on Diagonal Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagonal Bio.

Explore the full profile